Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Neurological effects of encapsulated dexamethasone sodium phosphate in children aged 6-9 years with ataxia telangiectasia (NEAT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Child & adolescent health
Published: March 11, 2026
Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders.
Journal: Frontiers in drug delivery
Published: October 22, 2025
Walking Capacity in Children With Ataxia Telangiectasia From the Global Ataxia Telangiectasia Family Data Platform.
Journal: Annals of the Child Neurology Society
Published: July 10, 2025
The ATTeST trial in ataxia telangiectasia: some concerns - Authors' response.
Journal: The Lancet. Neurology
Published: January 14, 2025
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasia.
Journal: Frontiers in neurology
Published: November 12, 2024
Evolution of the Florida Pediatric Bone Marrow Transplant and Cell Therapy Consortium (FPBCC): A Statewide Initiative Toward Improving Transplant Outcomes.
Journal: Pediatric transplantation
Published: October 14, 2024
Avatrombopag for severe refractory thrombocytopenia in a pediatric patient with ALL following allogeneic hematopoietic stem cell transplantation: A case report.
Journal: Leukemia research reports
Published: May 22, 2024
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Journal: The Lancet. Neurology
Published: January 26, 2024
The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia.
Journal: Pediatric transplantation
Published: December 04, 2023
Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study.
Journal: JCO precision oncology
Published: March 23, 2023
Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders.
Journal: Pediatric blood & cancer
Published: December 28, 2022
Last Updated: 09/26/2026